ReviewBest practice & research. Clinical endocrinology & metabolism2018
Treatment of hypoparathyroidism.
Review in Best practice & research. Clinical endocrinology & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Adverse events of proton pump inhibitor-associated parathyroid dysfunction: a real-world study based on the FDA adverse event reporting system.Irish journal of medical science · 2026Article
- Article
- Point-of-care ionised calcium testing: lab validation and clinical feasibility study.Endocrine connections · 2025Article
- Obesity and blunted FGF23 response associate with kidney impairment in patients with hypoparathyroidism.Endocrine · 2025Observational
- Coronary calcium score in patients with post-surgical hypoparathyroidism.Archives of endocrinology and metabolism · 2024Article
- Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond.Biomedicines · 2023Review
- The osteo-metabolic phenotype of COVID-19: an update.Endocrine · 2022Review
- UK national chronic hypoparathyroidism audit.Clinical endocrinology · 2022Article
- Article
- Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies.Journal of clinical medicine · 2022Article
- The Russian Registry of Chronic Hypoparathyroidism.Frontiers in endocrinology · 2022Observational
- Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?Reviews in endocrine & metabolic disorders · 2021Review
- Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects.Reviews in endocrine & metabolic disorders · 2021Review
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.Endocrine · 2021Article
- Hypovitaminosis D and the endocrine phenotype of COVID-19.Endocrine · 2021Review
- Endocrine and metabolic aspects of the COVID-19 pandemic.Reviews in endocrine & metabolic disorders · 2020Review
- Challenges in the management of chronic hypoparathyroidism.Endocrine connections · 2020Review
- Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.Endocrine · 2020Article
- Article
- Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report.World journal of clinical cases · 2019Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The goal of the clinical management of hypoparathyroidism is to correct acute and chronic hypocalcemia. Treatment of acute hypoparathyroidism via intravenous infusion of Ca++ salts, is necessary only in symptomatic patients, or in asymptomatic patients in the setting of a rapid decrease in ionized Ca
Indexed as
Identifiers
30551988What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.